NC-stat DPNCheck regulatory submission in China

|By:, SA News Editor

NeuroMetrix (NURO) applies for marketing clearance in China for its NC-stat DPNCheck peripheral neuropathy detection device. Once cleared, it will be marketed by the company's partner for Asian markets Omron Healthcare.

Approximately 100M Chinese have diabetes which comprises almost one quarter of the world total, making it the largest peripheral neuropathy diagnostic market by volume.